CVS Health Corp (NY:CVS)

86.46 +1.26 (+1.48%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

72 73 Next >

A Look Into CVS Health Inc's Price Over Earnings ↗

November 12, 2025

Via Benzinga

Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch ↗

November 12, 2025

Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share.

Via Benzinga

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."

Via Benzinga

CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap. ↗

November 11, 2025

The company replaced its CEO last year, and the turnaround has been going well.

Via The Motley Fool

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

Pete Buttigieg Slams Trump's 'Bad Deal' On Health Insurance, Cites CBO Estimate Of 10% Premium Hikes: 'Losing On The Economy' ↗

November 11, 2025

Pete Buttigieg says Trump's ATC attack is a distraction from his "bad deal" on health insurance and failure on "everyday life" costs.

Via Benzinga

Topics Government

Market Breathes Sigh of Relief: A Comprehensive Outlook Post-Government Shutdown Resolution

November 10, 2025

The financial markets are experiencing a significant resurgence of optimism as the United States government concludes its prolonged shutdown, which, at 40 days, marked the longest in the nation's...

Via MarketMinute

Topics Economy Regulatory Compliance Stocks

Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December ↗

November 10, 2025

Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to December and raising premium concerns.

Via Benzinga

UnitedHealth Group Stumbles Amidst Renewed Antitrust Scrutiny, Defying Bullish Market Trend

November 10, 2025

In a surprising turn of events on November 10, 2025, UnitedHealth Group (NYSE: UNH), a titan in the healthcare industry, saw its stock tumble significantly, shedding several percentage points of its...

Via MarketMinute

Topics Economy Stocks

Unpacking Q3 Earnings: Centene (NYSE:CNC) In The Context Of Other Health Insurance Providers Stocks

November 09, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Centene (NYSE:CNC) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill. ↗

November 09, 2025

Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.

Via The Motley Fool

Topics Stocks

Can CVS Health Maintain Its Growth Through the End of 2025? ↗

November 08, 2025

The company's prospects are looking up.

Via The Motley Fool

U.S. Labor Market Flashes Warning Signs: A November 2025 Economic Crossroads

November 07, 2025

The U.S. labor market is signaling a significant shift as November 2025 draws to a close, presenting a complex picture of decelerating job growth, a concerning surge in layoffs, and weakening consumer...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Humana Faces Steep Decline Amidst Broad Market Downturn: A Look at Potential Triggers and Industry Repercussions

November 06, 2025

November 6, 2025 – Humana Inc. (NYSE: HUM) shares experienced a significant downturn today, mirroring a broader negative trend across the market. While specific real-time triggers for this hypothetical...

Via MarketMinute

5 Revealing Analyst Questions From CVS Health’s Q3 Earnings Call

November 05, 2025

CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail...

Via StockStory

Topics Earnings

What the Options Market Tells Us About CVS Health ↗

October 31, 2025

Via Benzinga

Why CVS Health (CVS) Stock Is Falling Today

October 30, 2025

Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health...

Via StockStory

Topics Artificial Intelligence

CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook

October 30, 2025

Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was...

Via StockStory

CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High ↗

October 29, 2025

CVS Health topped Q3 estimates with $102.9 billion in revenue and raised its 2025 EPS outlook to up to $6.65 amid strong segment growth.

Via Benzinga

CVS Health Corp (NYSE:CVS) Q3 2025 Earnings Top Estimates, Raises Full-Year Outlook ↗

October 29, 2025

CVS Health Q3 2025 earnings smash estimates with record revenue of $102.9B and EPS of $1.60. The company also raises its full-year profit outlook.

Via Chartmill

CVS Health (NYSE:CVS) Delivers Strong Q3 Numbers

October 29, 2025

Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60...

Via StockStory

S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday? ↗

October 29, 2025

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100...

Via Benzinga

Topics Economy Stocks

Insights Ahead: CVS Health's Quarterly Earnings ↗

October 28, 2025

Via Benzinga

Earnings To Watch: CVS Health (CVS) Reports Q3 Results Tomorrow

October 27, 2025

Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Inflation Vs. Reality: Bilello Slams 'Clearly Wrong' Government Data Claiming Health Insurance Prices Fell 18%—Costs 'Only Go In One Direction' ↗

October 27, 2025

Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one direction."

Via Benzinga

Topics Economy

What Does the Market Think About CVS Health Corp? ↗

October 21, 2025

Via Benzinga

EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026 ↗

October 17, 2025

Trump and EMD Serono strike a deal to cut fertility drug costs, expand U.S. manufacturing, and launch the TrumpRx Fertility program in 2026.

Via Benzinga

Topics Government

CVS INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into CVS Health Corporation on Behalf of Long-Term Stockholders and Urges Investors to Contact the Firm

October 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

The Pharmacy Stock That's Cheaper Than It Should Be ↗

October 15, 2025

The company has crushed the market this year and still looks like a steal.

Via The Motley Fool

1 Healthcare Stock to Research Further and 2 We Find Risky

October 14, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.